Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq
16/10/2023 23:00
Oct 16 (Reuters) - Impel Pharmaceuticals Inc IMPL.O :
* IMPEL PHARMACEUTICALS - ON OCT 10 GOT LETTER FROM NASDAQ
THAT CO
HAD NOT REGAINED COMPLIANCE WITH RULES & ITS SECURITIES WILL BE
DELISTED
Further company coverage: IMPL.O
((reuters.briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq